Finance

Beta
Lists
SGP:NASDAQ
SpyGlass Pharma Inc
$18.32
-4.88%
(-0.94) 1D
Jun 1, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SGP...
Open
$19.20
High
$19.52
Low
$18.18
Mkt. cap
612.83M
Avg. vol.
59.87K
Volume
44.73K
52-wk high
$32.44
52-wk low
$18.18
No. of employees
65
Open
$19.20
High
$19.52
Low
$18.18
Mkt. cap
612.83M
Avg. vol.
59.87K
Volume
44.73K
52-wk high
$32.44
52-wk low
$18.18
No. of employees
65
News stories
From sources across the web
About SpyGlass Pharma Inc
CEO-
Employees65
Founded2019
HeadquartersAliso Viejo, California, United States
SectorPharmaceutical industry
Websitespyglasspharma.com
Last report
May 14, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.69 / -$0.36
-91.67%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Dec 2024
Dec 2025
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
5.74M
7.71M
Total research and development expenses
-
-
Selling, general, and admin expenses
2.01M
5.92M
Operating expense
7.75M
13.63M
Total operating expenses
7.75M
13.63M
Operating income
-7.75M
-13.63M
Other non operating income
-852.98K
11.00
EBT including unusual items
-8.40M
-12.56M
EBT excluding unusual items
-8.40M
-12.56M
Income tax expense
-
-
Effective tax rate
-
-
Other operating expenses
-
-
Net income
-8.40M
-12.56M
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
207.42K
1.07M
Interest expense
-
-
Net interest expenses
207.42K
1.07M
Depreciation and amortization charges
-
-
EBITDA
-7.65M
-13.41M
Gain or loss from assets sale
-
1.10K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer